
Innovation How cloud technology and storage are helping power AI
Learn how innovations in the cloud computing space are revolutionizing many Invesco QQQ ETF holdings.
Health care is undergoing a quiet revolution—one powered not just by breakthroughs in biology, but by cutting-edge technology. From artificial intelligence (AI) that helps interpret scans, to robots assisting in delicate surgeries, today’s health care innovators are reshaping what’s possible in diagnostics, treatment, and patient care.
Some Nasdaq-listed companies are at the forefront of this change by using technology to help solve some of the biggest challenges in modern medicine. These firms are helping health care providers deliver faster, smarter, and more personalized care—and their innovations could have a lasting impact on both medical outcomes and market opportunities.
For investors, that’s where Invesco QQQ ETF comes in. The ETF tracks the Nasdaq-100 Index, which includes many of the world’s most innovative companies. And while QQQ is widely associated with areas like AI, cloud computing, and e-commerce, it also offers exposure to several companies advancing medical technology—commonly referred to as “MedTech.”
The growth of the MedTech market is expected to be driven by rapid technological advancements, increasing health care expenditures, and the rising prevalence of chronic diseases. The market is projected to be valued at $549.5 billion in 2025 and is anticipated to reach $853.4 billion by 2035.1
Here are four MedTech names in QQQ helping to transform how medical professionals diagnose, monitor, and treat human (and animal) health. From robotic surgery to diagnostic tools for pets, these Nasdaq-listed innovators are changing the ways to monitor, treat, and think about health.
If surgery is an art, Intuitive Surgical is giving doctors the next-generation tools to refine their craft. Best known for its da Vinci Surgical System—a robotic platform that enhances a surgeon’s precision, vision, and control—Intuitive Surgical is helping shift more procedures toward minimally invasive techniques. That means smaller incisions, shorter recovery times, and potentially better outcomes.
The company continues to expand its platform and global footprint, making robotic-assisted surgery more accessible across a wider range of hospitals and specialties. As demand grows for smarter tools in the operating room, Intuitive Surgical appears well positioned at the intersection of health care and robotics.
Continuous glucose monitoring (CGM) may not sound futuristic—but for millions of people living with diabetes, it’s life-changing. Dexcom’s wearable CGM systems give users real-time insight into their blood sugar levels, reducing the need for finger sticks and helping manage diabetes more effectively.
What helps set Dexcom apart is its combination of hardware, software, and smart data integration. Recent models connect with smartphones and smartwatches, and the company is working to expand access for patients with Type 2 diabetes. Dexcom’s technology could play a key role in improving diabetic patients’ day-to-day care and long-term outcomes.
Magnetic resonance imaging. CT scans. Ultrasound. These are the workhorses of modern diagnostics—and GE HealthCare is one of the biggest players helping to make them smarter, faster, and more connected.
Now operating as an independent company, GE HealthCare is combining advanced imaging with artificial intelligence and cloud-based platforms. The goal? To help doctors detect diseases earlier, interpret results more accurately, and deliver personalized care plans. Its innovations span radiology, cardiology, and oncology—areas where better information can make all the difference.
In a world increasingly driven by data, GE HealthCare is giving clinicians the tools to turn scans into insights.
Not all diagnostics are just for humans. IDEXX Laboratories focuses on veterinary diagnostics and water testing, but don’t let that fool you—this company is every bit a MedTech innovator.
Its diagnostic platforms help vets quickly screen for diseases, monitor organ health, and detect early signs of illness in pets—from Labrador retrievers to tabby cats. It also offers lab testing services and digital imaging tools that bring hospital-grade technology to veterinary clinics.
With pet ownership on the rise and animals living longer, demand for high-quality veterinary care is growing fast.2 And IDEXX’s diagnostic know-how could make it one of the stealthiest innovators in the Nasdaq-100.
As medical technology continues to evolve, it’s not just doctors and patients who benefit—investors may, too. These four companies are just a few of the innovators within Invesco QQQ that are redefining the health care experience through robotics, data, diagnostics, and real-time monitoring.
While no single ETF can capture every aspect of a sector, QQQ offers exposure to many of the forces driving long-term change in how we live—and how we care for ourselves and others. From the operating room to the vet’s office, MedTech is proving that innovation doesn’t just move markets—it can improve lives.
Future Market Insights, Inc., as of April 2025.
In 2022, Americans spent $136.8 billion on their pets, up nearly 11% from 2021. Forbes.com, Pet Ownership Statistics 2025, as of January 2, 2025.
Select the option that best describes you, or view the QQQ Product Details to take a deeper dive.
Learn how innovations in the cloud computing space are revolutionizing many Invesco QQQ ETF holdings.
From live events to bingeable TV, learn how streaming services and changing the way we consume media.
Learn how digital technologies are revolutionizing the way fans engage with their favorite teams
NA4479869
Past performance is not a guarantee of future results.
This does not constitute a recommendation of any investment strategy or product for a particular investor. Investors should consult a financial professional/financial consultant before making any investment decisions.
The opinions expressed are those of the author, are based on current market conditions and are subject to change without notice. These opinions may differ from those of other Invesco investment professionals.
Forward-looking statements are not guarantees of future results. They involve risks, uncertainties and assumptions; there can be no assurance that actual results will not differ materially from expectations.
This information is provided for informational purposes and does not constitute an endorsement or recommendation of any companies referenced.
The Nasdaq-100® Index is a stock market index made up of equity securities issued by 100 of the largest non-financial companies listed on the Nasdaq stock exchange.
This content should not be construed as an endorsement for or recommendation to invest in Intuitive Surgical, Dexcom, GE Health, or IDEXX Laboratories. Intuitive Surgical, Dexcom, GE Health, nor IDEXX Laboratories are affiliated with Invesco. Only 4 of 101 underlying Invesco QQQ ETF fund holdings are featured. The companies referenced are meant to help illustrate representative innovative themes, not serve as a recommendation of individual securities. Holdings are subject to change and are not buy/sell recommendations. See invesco.com/qqq for current holdings. As of 5/6/2025, Intuitive Surgical, Dexcom, GE Health, and IDEXX Laboratories made up 1.28%, 0.21%, 0.21%, and 0.26%, respectively, of Invesco QQQ ETF.